Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-314,200
Closed -$408K 619
2022
Q4
$408K Hold
314,200
0.01% 450
2022
Q3
$559K Buy
314,200
+3,000
+1% +$7.47K 0.01% 617
2022
Q2
$706K Hold
311,200
0.01% 642
2022
Q1
$1.03M Sell
311,200
-700,600
-69% -$2.46M 0.01% 691
2021
Q4
$4.6M Buy
1,011,800
+66,200
+7% +$500K 0.04% 403
2021
Q3
$6.79M Buy
945,600
+75,000
+9% +$551K 0.06% 242
2021
Q2
$6.99M Buy
+870,600
New +$7.35M 0.05% 243

Other funds holding OCGN

Sculptor Capital's OCGN Position: Q1 2023 in Review

Sculptor Capital sold out of Ocugen (OCGN) in Q1 2023, closing a stake of 314,200 shares — an estimated $408K sold.

Sculptor Capital first reported a position in OCGN in Q2 2021 and held it in 7 quarters. The position peaked at $6.99M in Q2 2021. 103 funds tracked by Wall St. Rank hold OCGN as of Q1 2023.

  • Sculptor Capital reported no remaining Ocugen position as of Q1 2023 after selling out during the quarter.
  • Sculptor Capital sold 314,200 Ocugen shares in Q1 2023, an estimated $408K.
  • Sculptor Capital first reported a position in Ocugen in Q2 2021 and held it in 7 quarters.
  • Sculptor Capital's Ocugen position peaked at $6.99M in Q2 2021.
  • 103 funds tracked by Wall St. Rank held Ocugen as of Q1 2023.

Based on Sculptor Capital's 13F filing for Q1 2023, filed 16 May 2023.